ID   COV413B
AC   CVCL_2423
DR   EFO; EFO_0006558
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472965
DR   cancercelllines; CVCL_2423
DR   Cell_Model_Passport; SIDM01477
DR   ECACC; 07071906
DR   EGA; EGAS00001000610
DR   GEO; GSM1291137
DR   PharmacoDB; COV413B_256_2019
DR   Wikidata; Q54814345
RX   PubMed=8436435;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=25230021).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Urinary bladder, bladder dome; UBERON=UBERON_0006082.
ST   Source(s): ECACC; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 9,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 19
ST   Penta D: 14
ST   Penta E: 12,14
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2422 ! COV413A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 24
//
RX   PubMed=8436435; DOI=10.1002/ijc.2910530415;
RA   van den Berg-Bakker C.A.M., Hagemeijer A., Franken-Postma E.M.,
RA   Smit V.T.H.B.M., Kuppen P.J.K., van Ravenswaay Claasen H.H.,
RA   Cornelisse C.J., Schrier P.I.;
RT   "Establishment and characterization of 7 ovarian carcinoma cell lines
RT   and one granulosa tumor cell line: growth features and cytogenetics.";
RL   Int. J. Cancer 53:613-620(1993).
//
RX   PubMed=25230021; DOI=10.1371/journal.pone.0103988;
RA   Beaufort C.M., Helmijr J.C.A., Piskorz A.M., Hoogstraat M.,
RA   Ruigrok-Ritstier K., Besselink N., Murtaza M., van IJcken W.F.J.,
RA   Heine A.A.J., Smid M., Koudijs M.J., Brenton J.D., Berns E.M.J.J.,
RA   Helleman J.;
RT   "Ovarian cancer cell line panel (OCCP): clinical importance of in
RT   vitro morphological subtypes.";
RL   PLoS ONE 9:E103988-E103988(2014).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//